Category Archives: News and Events

BriaCell Announces Closing of Upsized Non-Brokered Private Placement of $846,301.49
September 9, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, September 9, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Participation at the 21st Annual Global Investment Conference in New York City September 8-10, 2019
August 27, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, August 27, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Appoints Richard J. Berman to Board of Directors
August 12, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, August 12, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces $350,000 Equity Investment by Board of Directors
July 23, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, July 23, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell’s Novel Technology and Clinical Data Published at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
May 28, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, May 28, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders
May 13, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, May 13, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Publication at American Society of Clinical Oncology (ASCO) Meeting and Presentation at Precision Breast Cancer Summit in Boston
April 23, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, April 23, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell’s Lead Candidate Combined With KEYTRUDA®: Strong Evidence of Rapid Additive or Synergistic Anti-Tumor Activity
April 3, 2019

• As presented at the American Association for Cancer Research (AACR) annual meeting: early efficacy ...

BriaCell Announces Clinical Trial Collaboration Agreement with Incyte
April 2, 2019

· BriaCell Therapeutics and Incyte have formed a non-exclusive clinical trial collaboration to evaluate the ...

BriaCell Announces Closing of Upsized & Oversubscribed Non-Brokered Private Placement of $2.97 Million
April 1, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, April 1, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

Skip to content